| MicroRNA: A signature for cancer progression BM Hussen, HJ Hidayat, A Salihi, DK Sabir, M Taheri, S Ghafouri-Fard Biomedicine & Pharmacotherapy 138, 111528, 2021 | 265 | 2021 |
| H19 lncRNA: roles in tumorigenesis S Ghafouri-Fard, M Esmaeili, M Taheri Biomedicine & Pharmacotherapy 123, 109774, 2020 | 260 | 2020 |
| Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA S Ghafouri-Fard, M Taheri Biomedicine & Pharmacotherapy 118, 109129, 2019 | 164 | 2019 |
| Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy MF Rasul, BM Hussen, A Salihi, BS Ismael, PJ Jalal, A Zanichelli, ... Molecular Cancer 21 (1), 1-30, 2022 | 133 | 2022 |
| 5-Fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent S Ghafouri-Fard, A Abak, F Tondro Anamag, H Shoorei, F Fattahi, ... Frontiers in Oncology 11, 658636, 2021 | 130 | 2021 |
| miRNA profile in ovarian cancer S Ghafouri-Fard, H Shoorei, M Taheri Experimental and molecular pathology 113, 104381, 2020 | 128 | 2020 |
| Role of miRNA and lncRNAs in organ fibrosis and aging S Ghafouri-Fard, A Abak, SF Talebi, H Shoorei, W Branicki, M Taheri, ... Biomedicine & Pharmacotherapy 143, 112132, 2021 | 123 | 2021 |
| DNA methylation-based age clocks: From age prediction to age reversion R Noroozi, S Ghafouri-Fard, A Pisarek, J Rudnicka, M Spolnicka, ... Ageing Research Reviews 68, 101314, 2021 | 119 | 2021 |
| Interplay between PI3K/AKT pathway and heart disorders S Ghafouri-Fard, A Khanbabapour Sasi, BM Hussen, H Shoorei, A Siddiq, ... Molecular biology reports 49 (10), 9767-9781, 2022 | 117 | 2022 |
| Application of machine learning in diagnosis of COVID-19 through X-ray and CT images: a scoping review H Mohammad-Rahimi, M Nadimi, A Ghalyanchi-Langeroudi, M Taheri, ... Frontiers in cardiovascular medicine 8, 638011, 2021 | 117 | 2021 |
| Non-coding RNAs participate in the ischemia-reperfusion injury S Ghafouri-Fard, H Shoorei, M Taheri Biomedicine & Pharmacotherapy 129, 110419, 2020 | 104 | 2020 |
| Nuclear enriched abundant transcript 1 (NEAT1): a long non-coding RNA with diverse functions in tumorigenesis S Ghafouri-Fard, M Taheri Biomedicine & Pharmacotherapy 111, 51-59, 2019 | 94 | 2019 |
| Long non-coding RNA signature in gastric cancer S Ghafouri-Fard, M Taheri Experimental and molecular pathology 113, 104365, 2020 | 88 | 2020 |
| Cytokine profile in autistic patients MM Eftekharian, S Ghafouri-Fard, R Noroozi, MD Omrani, S Arsang-Jang, ... Cytokine 108, 120-126, 2018 | 85 | 2018 |
| Long non-coding RNA expression in bladder cancer M Taheri, MD Omrani, S Ghafouri-Fard Biophysical reviews 10, 1205-1213, 2018 | 85 | 2018 |
| A review on the role of cyclin dependent kinases in cancers S Ghafouri-Fard, T Khoshbakht, BM Hussen, P Dong, N Gassler, M Taheri, ... Cancer Cell International 22 (1), 325, 2022 | 84 | 2022 |
| HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population M Taheri, M Habibi, R Noroozi, A Rakhshan, S Sarrafzadeh, A Sayad, ... Gene 613, 20-24, 2017 | 84 | 2017 |
| The role of non-coding RNAs in controlling cell cycle related proteins in cancer cells S Ghafouri-Fard, H Shoorei, FT Anamag, M Taheri Frontiers in Oncology 10, 608975, 2020 | 83 | 2020 |
| Emerging impact of quercetin in the treatment of prostate cancer S Ghafouri-Fard, FA Shabestari, S Vaezi, A Abak, H Shoorei, A Karimi, ... Biomedicine & Pharmacotherapy 138, 111548, 2021 | 82 | 2021 |
| Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions R Noroozi, W Branicki, K Pyrc, PP Łabaj, E Pospiech, M Taheri, ... Cytokine 133, 155143, 2020 | 80 | 2020 |
Soudeh Ghafouri-FardShahid Beheshti University of Medical SciencesVahvistettu sähköpostiosoite verkkotunnuksessa sbmu.ac.ir
